Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Vickery BP, Vereda A, Nilsson C, du Toit G, Shreffler WG, Burks AW, Jones SM, Fernández-Rivas M, Blümchen K, O'B Hourihane J, Beyer K, Anagnostou A, Assa'ad AH, Ben-Shoshan M, Bird JA, Carr TF, Carr WW, Casale TB, Chong HJ, Ciaccio CE, Dorsey MJ, Fineman SM, Fritz SB, Greiner AN, Greos LS, Hampel FC Jr, Ibáñez MD, Jeong DK, Johnston DT, Kachru R, Kim EH, Lanser BJ, Leonard SA, Maier MC, Mansfield LE, Muraro A, Ohayon JA, Oude Elberink JNG, Petroni DH, Pongracic JA, Portnoy JM, Rachid R, Rupp NT, Sanders GM, Sharma HP, Sharma V, Sher ER, Sher L, Sindher SB, Siri D, Spergel JM, Sprikkelman AB, Sussman GL, Tsoumani M, Varshney P, Vitalpur G, Wang J, Yang WH, Zubeldia JM, Smith A, Ryan R, Adelman DC. Vickery BP, et al. Among authors: zubeldia jm. J Allergy Clin Immunol Pract. 2021 May;9(5):1879-1889.e13. doi: 10.1016/j.jaip.2020.12.029. Epub 2020 Dec 24. J Allergy Clin Immunol Pract. 2021. PMID: 33359589 Free article. Clinical Trial.
Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice.
Marco-Martín G, La Rotta Hernández A, Vázquez de la Torre M, Higaki Y, Zubeldia JM, Baeza ML. Marco-Martín G, et al. Among authors: zubeldia jm. Int Arch Allergy Immunol. 2017;173(4):204-212. doi: 10.1159/000478983. Epub 2017 Aug 30. Int Arch Allergy Immunol. 2017. PMID: 28850948 Free article.
AR101 Oral Immunotherapy for Peanut Allergy.
PALISADE Group of Clinical Investigators; Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC Jr, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW. PALISADE Group of Clinical Investigators, et al. Among authors: zubeldia jm. N Engl J Med. 2018 Nov 22;379(21):1991-2001. doi: 10.1056/NEJMoa1812856. Epub 2018 Nov 18. N Engl J Med. 2018. PMID: 30449234 Clinical Trial.
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial.
Gastaminza G, Azofra J, Nunez-Cordoba JM, Baeza ML, Echechipía S, Gaig P, García BE, Labrador-Horrillo M, Sala-Cunill A, Brescó MS, Beristain A, Quiñones D, Donado CD, Zubeldia JM, Ferrer M. Gastaminza G, et al. Among authors: zubeldia jm. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1599-1609.e1. doi: 10.1016/j.jaip.2018.12.025. Epub 2019 Jan 15. J Allergy Clin Immunol Pract. 2019. PMID: 30654196 Clinical Trial.
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J, Beyer K, Abbas A, Fernández-Rivas M, Turner PJ, Blumchen K, Nilsson C, Ibáñez MD, Deschildre A, Muraro A, Sharma V, Erlewyn-Lajeunesse M, Zubeldia JM, De Blay F, Sauvage CD, Byrne A, Chapman J, Boralevi F, DunnGalvin A, O'Neill C, Norval D, Vereda A, Skeel B, Adelman DC, du Toit G. O'B Hourihane J, et al. Among authors: zubeldia jm. Lancet Child Adolesc Health. 2020 Oct;4(10):728-739. doi: 10.1016/S2352-4642(20)30234-0. Epub 2020 Jul 20. Lancet Child Adolesc Health. 2020. PMID: 32702315 Clinical Trial.
The Natural Course of Adult-Onset Food Protein-Induced Enterocolitis Syndrome.
Crespo J, Pérez-Pallise ME, Skrabski F, Zambrano G, Rojas-Pérez-Ezquerra P, Noguerado-Mellado B, Zubeldia JM, Infante S. Crespo J, et al. Among authors: zubeldia jm. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2986-2992. doi: 10.1016/j.jaip.2022.06.013. Epub 2022 Jun 23. J Allergy Clin Immunol Pract. 2022. PMID: 35753669
Hypersensitivity pneumonitis caused by soybean antigens.
Zubeldia JM, Gil P, Miralles P, de Barrio M, Aranzábal A, Herrero T, Rubio M, Bouzas E, Baeza ML. Zubeldia JM, et al. J Allergy Clin Immunol. 1995 Feb;95(2):622-6. doi: 10.1016/s0091-6749(95)70325-x. J Allergy Clin Immunol. 1995. PMID: 7852674 No abstract available.
71 results